Essilorluxottica Acquires Retinai
EssilorLuxottica announces the acquisition of Ikerian AG, operating under the RetinAI brand, specializing in AI and data management in eyecare.
This move reinforces the Group’s med-tech journey, adding advanced software powered by machine learning and computer vision.
- Streamline clinical, research and pharmaceutical workflows
- Deliver actionable AI-driven insights that empower healthcare professionals and enhance patient care
RetinAI develops advanced tools to collect, process and grade large-scale retinal images and biomarker datasets.
RetinAI partners with pharmaceutical companies and research organizations to accelerate clinical studies and drug development.
Author's summary: EssilorLuxottica acquires Retinai for AI eye health solutions.
More News
- Fatah: The PLO and the State of Palestine remain the sole legitimate framework for protecting the national project
- Minister of Education Haruna Iddrisu celebrates Mawuli School’s 75th anniversary, cuts sod for new dormitories - MyJoyOnline
- Raiders welcome Grambling State, Jackson State for HBCU Classic in Las Vegas
- The Orion takes first place in national journalism contest